ACQUIRED · 2025
Who Acquired OPKO / BioReference Health (Clinical Diagnostics Business)?
Labcorp · $192.5M
The acquisition
OPKO / BioReference Health (Clinical Diagnostics Business) was acquired by Labcorp in 2025 for $192.5M. at 2.10× revenue.
OPKO / BioReference Health (Clinical Diagnostics Business) at time of acquisition
Revenue
$92.5M
Deal value
$192.5M
Other acquisitions by Labcorp
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- OPKO / BioReference Clinical Diagnostics Business · 2024 · $237.6M
Similar laboratory services acquisitions
- GeneSeek (Neogen Animal Genomics) · acquired by Zoetis in 2026 · $160.0M
- CHS Outreach Laboratory Assets · acquired by Laboratory Corporation of America Holdings in 2025 · $194.5M
- Akoya Biosciences, Inc. · acquired by Quanterix Corporation in 2025 · $286.0M
- Enzo Biochem, Inc. · acquired by Battery Ventures in 2025 · $37.0M
- Exact Sciences · acquired by Abbott in 2025 · $21.00B
Run a valuation for a similar laboratory services business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the laboratory services calculator →More on laboratory services valuations
- Laboratory Services valuation calculator· head-term variant
- Laboratory Services median multiples· real-deal benchmarks
- How to value a laboratory services· long-form guide
Sourced from SEC filings and press releases. Full deal page.
Citation: ExitValue.ai. (2025). OPKO / BioReference Health (Clinical Diagnostics Business) acquired by Labcorp. https://exitvalue.ai/acquired/opko-bioreference-health-clinical-diagnostics-business